A QbD-informed study of permeation enhancer–octreotide nanoscale interactions influencing performance in pullulan buccal films

Sahil Malhotra, Sandeep Karki, Holly Linford, Muhammad Ijaz, Jimmy Muldoon, Ehsan Rezvani, Antonio Benedetto, Arun HS Kumar, Eoin O’ Cearbhaill, David J. Brayden

Open source

DOI
10.1016/j.ijpharm.2026.126730
Published
2026-04
Container
International Journal of Pharmaceutics
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.ijpharm.2026.126730,
  title = {A QbD-informed study of permeation enhancer–octreotide nanoscale interactions influencing performance in pullulan buccal films},
  author = {Sahil Malhotra and Sandeep Karki and Holly Linford and Muhammad Ijaz and Jimmy Muldoon and Ehsan Rezvani and Antonio Benedetto and Arun HS Kumar and Eoin O’ Cearbhaill and David J. Brayden},
  year = {2026},
  journal = {International Journal of Pharmaceutics},
  doi = {10.1016/j.ijpharm.2026.126730},
  url = {https://doi.org/10.1016/j.ijpharm.2026.126730}
}

RIS

TY  - JOUR
TI  - A QbD-informed study of permeation enhancer–octreotide nanoscale interactions influencing performance in pullulan buccal films
AU  - Sahil Malhotra
AU  - Sandeep Karki
AU  - Holly Linford
AU  - Muhammad Ijaz
AU  - Jimmy Muldoon
AU  - Ehsan Rezvani
AU  - Antonio Benedetto
AU  - Arun HS Kumar
AU  - Eoin O’ Cearbhaill
AU  - David J. Brayden
PY  - 2026
JO  - International Journal of Pharmaceutics
DO  - 10.1016/j.ijpharm.2026.126730
UR  - https://doi.org/10.1016/j.ijpharm.2026.126730
ER  - 

APA

Malhotra, S., Karki, S., Linford, H., Ijaz, M., Muldoon, J., Rezvani, E., Benedetto, A., Kumar, A. H., Cearbhaill, E. O., & Brayden, D. J. (2026). A QbD-informed study of permeation enhancer–octreotide nanoscale interactions influencing performance in pullulan buccal films. International Journal of Pharmaceutics. https://doi.org/10.1016/j.ijpharm.2026.126730

Source records